Laboratory data revealed moderate to severe elevation of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in 3 patients (42.9%) in the PHL group, and in 5 patients (38.5%) in the DLBCL-liver group. This evidence concerns the gene GPT and diffuse large B-cell lymphoma.